Improvement of diabetic retinopathy screening of diabetic patients seen at the Internal Medicine Clinic​​

Presenter Information (List ALL Authors)

Jorge Nadal, The University of Texas Rio Grande ValleyFollow
Carol Soler, The University of Texas Rio Grande ValleyFollow
Mery Bartl, The University of Texas Rio Grande ValleyFollow
Jose Gomez, The University of Texas Rio Grande ValleyFollow
Michelle Lopez, The University of Texas Rio Grande ValleyFollow
Blesset Alexander, The University of Texas Rio Grande ValleyFollow
Gabriel Lora, The University of Texas Rio Grande ValleyFollow
Azucena del Real, The University of Texas Rio Grande ValleyFollow
Maria Pesantez, The University of Texas Rio Grande ValleyFollow
Sergio Saenz, The University of Texas Rio Grande ValleyFollow
Jorge A. Bernal, The University of Texas Rio Grande ValleyFollow

Presenting Author

Jorge Nadal

Presentation Type

Poster

Discipline Track

Community/Public Health

Abstract Type

Program Abstract

Abstract

Diabetic retinopathy (DR) is a leading cause of vision loss globally. The International Diabetes Federation (IDF) estimated the global population with diabetes to be 463 million in 2019 and 700 million in 2045. Retinopathy is a highly specific neurovascular complication of both type 1 and types 2 diabetes, and the prevalence strongly correlates to both the duration of diabetes and the level of glycemic control. Regular follow-up with early detection and treatment of vision-threatening retinopathy enables the prevention of up to 98% of visual loss due to diabetic retinopathy.

Recommended Citation

Nadal, Jorge; Soler, Carol; Bartl, Mery; Gomez, Jose; Lopez, Michelle; Alexander, Blesset; Lora, Gabriel; del Real, Azucena; Pesantez, Maria; Saenz, Sergio; and Bernal, Jorge A., "Improvement of diabetic retinopathy screening of diabetic patients seen at the Internal Medicine Clinic​​" (2023). Research Symposium. 46.
https://scholarworks.utrgv.edu/somrs/2022/posters/46